Ending the TB pandemic: the urgency of a new and improved TB vaccine and the World Health Organization's TB Vaccine Accelerator Council
- PMID: 37719240
- PMCID: PMC10501705
- DOI: 10.1183/20734735.0036-2023
Ending the TB pandemic: the urgency of a new and improved TB vaccine and the World Health Organization's TB Vaccine Accelerator Council
Abstract
We support the World Health Organization (WHO) recent decision to create a council to accelerate the development of a tuberculosis (TB) vaccine. With over 10 million new cases and 1.4 million deaths in 2020 alone, new and improved vaccines are urgently needed. Recent advancements in TB vaccine research offer hope, but a lack of funding, coordination and understanding of immune responses have impeded progress. A TB Vaccine Accelerator Council aims to bring together resources and expertise to overcome these obstacles and speed up development. Support and investment in research are crucial to ultimately eradicate TB and achieve the WHO goal of ending TB by 2035.
Copyright ©ERS 2023.
Conflict of interest statement
Conflict of interest: The authors have nothing to disclose.
Comment in
-
The changing face of the modern respiratory clinician.Breathe (Sheff). 2023 Sep;19(3):230147. doi: 10.1183/20734735.0147-2023. Epub 2023 Sep 12. Breathe (Sheff). 2023. PMID: 37732949 Free PMC article.
Similar articles
-
The critical role of new tuberculosis vaccines in achieving the WHO 2035 End TB target.IJID Reg. 2025 Mar 19;14(Suppl 2):100595. doi: 10.1016/j.ijregi.2025.100595. eCollection 2025 Mar. IJID Reg. 2025. PMID: 40201559 Free PMC article. Review.
-
[Recent progress in mycobacteriology].Kekkaku. 2007 Oct;82(10):783-99. Kekkaku. 2007. PMID: 18018602 Japanese.
-
Tuberculosis: a new vision for the 21st century.Kekkaku. 2009 Nov;84(11):721-6. Kekkaku. 2009. PMID: 19999594
-
Adjuvant Strategies for More Effective Tuberculosis Vaccine Immunity.Microorganisms. 2019 Aug 12;7(8):255. doi: 10.3390/microorganisms7080255. Microorganisms. 2019. PMID: 31409028 Free PMC article. Review.
-
Drug-resistant TB: deadly, costly and in need of a vaccine.Trans R Soc Trop Med Hyg. 2016 Mar;110(3):186-91. doi: 10.1093/trstmh/trw006. Trans R Soc Trop Med Hyg. 2016. PMID: 26884499 Free PMC article. Review.
Cited by
-
Assessment of tuberculosis drug efficacy using preclinical animal models and in vitro predictive techniques.NPJ Antimicrob Resist. 2024 Dec 16;2(1):49. doi: 10.1038/s44259-024-00066-z. NPJ Antimicrob Resist. 2024. PMID: 39843983 Free PMC article.
-
The changing face of the modern respiratory clinician.Breathe (Sheff). 2023 Sep;19(3):230147. doi: 10.1183/20734735.0147-2023. Epub 2023 Sep 12. Breathe (Sheff). 2023. PMID: 37732949 Free PMC article.
References
-
- United Nations . WHO launches Council to develop TB vaccines, hoping to save millions of lives. Date last updated: 17 January 2023. https://news.un.org/en/story/2023/01/1132552
-
- World Health Organization . Global tuberculosis report 2021. Geneva, World Health Organization, 2021.
-
- World Health Organization . Global tuberculosis report 2022. Geneva, World Health Organization, 2022.
LinkOut - more resources
Full Text Sources